C07D 211/04
Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings: with
Official title: with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
C07D211/04 (Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings: with) appears on 9,224 US grants and 7,675 published applications in this corpus.
Search patents in C07D- Granted patents
- 9,224
- Published applications
- 7,675
- Assignees
- 2,778
- Inventors
- 21,201
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 144 | 0 |
| 1977 | 159 | 0 |
| 1978 | 167 | 0 |
| 1979 | 124 | 0 |
| 1980 | 139 | 0 |
| 1981 | 132 | 0 |
| 1982 | 122 | 0 |
| 1983 | 106 | 0 |
| 1984 | 97 | 0 |
| 1985 | 146 | 0 |
| 1986 | 116 | 0 |
| 1987 | 108 | 0 |
| 1988 | 126 | 0 |
| 1989 | 158 | 0 |
| 1990 | 129 | 0 |
| 1991 | 152 | 0 |
| 1992 | 149 | 0 |
| 1993 | 167 | 0 |
| 1994 | 150 | 0 |
| 1995 | 136 | 0 |
| 1996 | 156 | 0 |
| 1997 | 248 | 0 |
| 1998 | 201 | 0 |
| 1999 | 200 | 0 |
| 2000 | 202 | 0 |
| 2001 | 204 | 61 |
| 2002 | 272 | 294 |
| 2003 | 245 | 373 |
| 2004 | 209 | 461 |
| 2005 | 200 | 389 |
| 2006 | 208 | 405 |
| 2007 | 193 | 353 |
| 2008 | 175 | 288 |
| 2009 | 238 | 352 |
| 2010 | 253 | 400 |
| 2011 | 184 | 321 |
| 2012 | 249 | 248 |
| 2013 | 253 | 247 |
| 2014 | 234 | 293 |
| 2015 | 269 | 324 |
| 2016 | 230 | 313 |
| 2017 | 275 | 293 |
| 2018 | 226 | 315 |
| 2019 | 261 | 258 |
| 2020 | 215 | 282 |
| 2021 | 204 | 239 |
| 2022 | 158 | 260 |
| 2023 | 152 | 273 |
| 2024 | 138 | 233 |
| 2025 | 152 | 254 |
| 2026 | 93 | 146 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- Cationic lipid having disulfide bond, lipid membrane structure including same, nucleic acid introduction agent and pharmaceutical composition containing any one of same, method for introducing nucleic acid into cell or target cell, and method for producing cellular pharmaceutical29 Sep 2026US 12,746,202 B2National University Corporation Chiba University
- Capsaicin analogs and uses thereof29 Sep 2026US 12,747,200 B2Young BioPharma, LLC
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Cobalt-catalyzed carbonylative alkene hydrofunctionalizations promoted by visible light8 Oct 2026US 2026/0308103 A1
- Probenecid compounds for the treatment of inflammasome-mediated lung disease8 Oct 2026US 2026/0308131 A1Bacainn Biotherapeutics, Ltd.
- Estrogen-receptor modulator and use thereof8 Oct 2026US 2026/0308139 A1Jiangsu Vcare PharmaTech Co., Ltd.
- Novel compound or salt thereof, catalyst, method of preparing novel compound or salt thereof and method of preparing mannich product8 Oct 2026US 2026/0308178 A1Okinawa Institute of Science and Technology School Corporation
- Amino acid backbone ionizable lipid, preparation method thereof and application method therefor1 Oct 2026US 2026/0294811 A1South China University of Technology
Most cited
By later US patents
- Delivery of multiple doses of medications377US 5,837,284 A1998
- Antidiabetic 3,4,5-trihydroxypiperidines252US 4,639,436 ABayer Aktiengesellschaft · 1987
- Methods and compositions for determining the sequence of nucleic acid molecules245US 6,312,893 B1QIAGEN Genomics, Inc. · 2001
- Proline derivatives and related compounds230US 4,105,776 AE. R. Squibb & Sons, Inc. · 1978
- Pharmaceutical formulations for parenteral use208US 5,024,998 AUniversity of Florida · 1991